Integer Holdings (ITGR) Stock Price

Integer Holdings Price

NYSE·CLOSED
126.70
​
Market closed

Revenue has compounded at 10.6% per year over the past 19 years to 1.85 B USD. Earnings per share have grown at 7.6% per year over the last 19 years. Integer Holdings's net margin stands at 5.6%, down from 7.9% several years earlier. Analysts set a median price target of 115.00 USD, implying 9.2% below the current price. Of 15 analysts, 0 rate the stock a buy — an overall Hold consensus.

Integer Holdings stock price

Access this data via the Eulerpool API

Integer Holdings business model & stock analysis

Integer Holdings Corp is a globally leading medical technology company that provides a wide range of products and services to customers in various fields. The company was founded in 1979 by a man named Donald M. Stelling to develop medical devices. The company has since grown significantly and has become one of the leading providers of medical technology products. Its business model is based on providing high-quality and innovative products tailored to the needs of customers. Integer Holdings Corp is divided into four business segments. The first segment is Medical Devices, where solutions are developed for patients and medical professionals. This includes the production of catheters, medical pumps, and precision measurement devices, which play an important role in the medical care of patients. The segment specializes in the development of customized solutions for OEM manufacturers. The second segment is Power Solutions, where high-quality batteries, chargers, and power packs are manufactured for a wide range of medical devices. These batteries are designed for a long lifespan and ensure reliable power supply for medical devices. In the third segment, Advanced Surgical, innovative solutions for surgery are developed, such as suction and cutting devices for minimally invasive procedures. The modern surgical instruments offer high precision and are tailored to the needs of patients, surgeons, and clinics. The fourth and final segment is Cardio & Vascular, where products for the treatment of cardiovascular diseases are manufactured. This includes stents, balloon catheters, and pacemakers, among others. They assist doctors in monitoring and regulating the condition of patients. Overall, the company offers a wide range of products that are essential for the medical care of patients and the work of clinic staff and medical professionals. Integer Holdings Corp is committed to meeting the needs of its customers through innovative solutions. The company also has a strong commitment to quality and safety. It maintains strict controls and systems to ensure that all products meet the highest standards. Integer Holdings Corp is also dedicated to sustainable manufacturing and environmentally friendly disposal of medical technology. Overall, Integer Holdings Corp is a leading provider of medical technology products, distinguished by its innovative and customer-oriented business model. With its solutions in the Medical Devices, Power Solutions, Advanced Surgical, and Cardio & Vascular segments, the company ensures that patients and medical professionals always have access to the best technologies and products to ensure successful treatment of diseases and injuries.

Frequently asked questions about Integer Holdings

The business model of Integer Holdings Corp, a leading medical device outsource manufacturer, revolves around providing innovative solutions and advanced technologies to the healthcare industry. Integer offers a comprehensive range of products and services, including advanced surgical instruments, cardiac rhythm management devices, neuromodulation and spinal cord stimulation systems, and various other medical devices. By leveraging their extensive expertise, state-of-the-art facilities, and strong industry partnerships, Integer caters to the increasing demand for high-quality healthcare solutions. With a focus on driving improvements and enhancing patient outcomes, Integer Holdings Corp remains committed to delivering exceptional medical device manufacturing services worldwide.

Integer Holdings Corp is primarily active in the medical technology industry.

The main competitors of Integer Holdings Corp in the market include Medtronic, Johnson & Johnson, and Stryker Corporation.

Integer Holdings Corp, also known as Integer, is a leading medical device outsource manufacturer based in Texas. The company has a rich history, originally founded in 1947 as Medrad, which focused on manufacturing contrast delivery systems for medical imaging procedures. In 2011, the company was acquired by Boston Scientific and was later spun off as an independent company in 2016, rebranding as Integer Holdings Corp. With over 70 years of experience, Integer has become a trusted partner in the medical device industry, offering innovative solutions and comprehensive manufacturing capabilities. Today, Integer continues to drive advancements in medical technology, delivering high-quality products to improve patient care globally.

Integer Holdings Corp, a leader in medical device outsourcing, has achieved numerous significant milestones throughout its history. The company has continuously focused on innovation, collaborating with leading healthcare organizations to develop cutting-edge solutions that address critical medical needs. Integer Holdings Corp has maintained a strong track record of delivering high-quality products and services, earning the trust of its global customers. With a commitment to manufacturing excellence and a broad portfolio of medical technologies, the company has successfully positioned itself as a trusted partner in the highly regulated healthcare industry. Integer Holdings Corp's dedication to advancing healthcare through its expertise and comprehensive offerings has solidified its position as a key player in the market.

Integer Holdings Corp is primarily present in various countries and regions, including the United States, Germany, Italy, Switzerland, France, the United Kingdom, Mexico, Singapore, and Malaysia.

Integer Holdings Corp represents values of innovation, quality, and integrity in the medical device industry. The company is committed to designing and manufacturing advanced solutions that improve patient outcomes and healthcare experiences. With a strong focus on research and development, Integer strives to create groundbreaking technologies and deliver cutting-edge products to medical professionals worldwide. As a responsible corporate citizen, Integer upholds the highest ethical standards and ensures compliance with regulatory requirements. The company's dedication to excellence and commitment to customers make Integer Holdings Corp a trusted and reliable partner in the healthcare industry.

Analysts currently set an average price target of 114.80 USD for the Integer Holdings stock (median: 115.00 USD), implying -9.4 % versus the latest price. The consensus is based on 15 analyst ratings.

15 analysts currently rate the Integer Holdings stock: 0 recommend buying, 12 holding and 3 selling. For 2026, analysts expect Integer Holdings to generate revenue of 1.82 B USD and earnings per share of 6.23 USD.

Converted at the current exchange rate, the Integer Holdings share trades at 113.09 EUR (126.70 USD).

The Integer Holdings share (ITGR) is listed on 4 stock exchanges, including: NYSE (ITGR), SIX (Zürich) (WGB.SW), Frankfurt (WGB.F), München (WGB.MU).

Integer Holdings Corp is a leading company in the medical technology industry. It operates globally and offers innovative solutions for a variety of medical applications. The business model of Integer Holdings Corp is based on four different business segments: Cardio & Vascular, Neuromodulation, Advanced Surgical, and Orthopedics.

The expected revenue of Integer Holdings is 1.82 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Integer Holdings is 219.04 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Integer Holdings is currently 20.33. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Integer Holdings stock.

The price-to-sales ratio (P/S) of Integer Holdings is currently 2.45. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Integer Holdings stock.

The Eulerpool Quality Score for Integer Holdings is 6/10.

The ISIN of Integer Holdings is US45826H1095. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Integer Holdings is A2AMZW. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Integer Holdings is ITGR. The ticker symbol is used to trade Integer Holdings shares on the stock exchange.

Fair ValueTerminal
126.70 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
167,860.55 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website integer.net
Currency
USD
Initial public offering
Sep 29, 2000
ISIN
US45826H1095
Cusip
45826H109
Sedol
BD06LM7
Market capitalization
4.51 B USDMid Cap
52-Week Range
PEG
5.04
P/E ratio
P/Ee 2026
20.59
P/Ee 2027
18.46
P/Ee 2028
17.33
P/Ee 2029
14.80
P/S
P/Se
2.45
EV/EBIT
27.22
P/B Ratio
2.58
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
3.46 %
Last updated Oct 12, 2026, 5:51 PM

Integer Holdings Ticker

FRANKFURT · WGB.FMUNICH · WGB.MUNEW YORK · ITGRSIX · WGB.SW

Integer Holdings FIGI

ITGREUR:XF · BBG00D8MWD46ITGR:US · BBG000BW6JV4ITGR:UA · BBG000BW6LR4ITGR:UC · BBG000BW6MH3ITGR:UN · BBG000BW6NN4ITGR:UP · BBG000BW6P77ITGR:UB · BBG000BW6Q57ITGR:UT · BBG000BW6QM8ITGR:UM · BBG000BW6QZ4ITGR:UX · BBG000BW6RS0ITGR:UD · BBG000BW6V92ITGR:UF · BBG000BW6WQ1